2023

Jayasree K. Iyer, PhD, MSc, CEO of the Access to Medicine Foundation, opened the Global Summit and highlighted the unmet pharmacological needs of a significant portion of the world’s population. In many parts of the world, access to drugs to treat rheumatic diseases, in particular,…

In the first of three plenary sessions, researchers will discuss new developments in rheumatic disease and pregnancy, the pathogenesis of systemic lupus erythematous-associated pulmonary arterial hypertension, sexually dimorphic gene expression of synovial macrophages in rheumatoid arthritis, therapy for severe granulomatosis with polyangiitis and microscopic polyangiitis,…

Cornelia M. Weyand, MD, PhD, will explain how the bioenergetic stress experienced by the immune system of a person living with rheumatoid arthritis causes their immune cells to malfunction. For the past 50 years, providers have traditionally suppressed patients’ immune systems with inhibitors to eliminate…

Attendees will learn concepts and terminology related to LGBTQIA+ identities, as well as the effects of stigma, minority stress, and health disparities experienced by these individuals in the healthcare setting. “We want everyone that comes through our hospital or clinic to feel welcome,” said Cameron…

Researchers are just beginning to piece together the roles of various environmental perturbations on osteoarthritis (OA). Matlock Jeffries, MD, will discuss the articular microbiome in OA, including its potential role in OA pathogenesis, as part of a panel on microbiome niches.

Many potential symptoms are associated with vasculitis affecting the central nervous system, making diagnosis challenging. Rula A. Hajj-Ali, MD, will review case-based assessments to explore the pitfalls of diagnosis, multiple diagnostic modalities, and mimics for CNS vasculitis.

Timely diagnosis and effective treatment are critical to outcomes for childhood-onset systemic lupus erythematosus. Mark Mitsnefes, MD, MS, and other experts will discuss the potential of histology and biomarkers as prognostic markers and examine anti-hypertensive and other non-immunological treatments.